Literature DB >> 1723371

The use of antidepressants in the treatment of chronic pain. A review of the current evidence.

G Magni1.   

Abstract

In the last 30 years antidepressant drugs have been used increasingly in the treatment of patients with chronic pain. This article reviews the results of some 40 placebo-controlled studies. It is difficult to make comparisons between the various studies because they often differ in terms of pain conditions, patient selection, antidepressant drug used, dosages, trial design, etc. However, in spite of this heterogeneity and other methodological problems it is clear that a wide range of pain conditions are responsive to antidepressant drug treatment, in particular: headache, migraine, facial pain, neurogenic pain, fibrositis, and probably arthritis and rheumatoid arthritis. More data need to be gathered in cancer pain, and in other conditions such as low back pain for which no, or very limited, effect has been shown. The beneficial effects of antidepressant drugs is in most cases of a mild to moderate degree, some time lag is necessary before it is completely manifest, and it tends to persist over time if drug treatment is continued in the long term. Strong evidence of efficacy is not evident for all the antidepressants, and there are probably significant differences in this respect between various drugs. The effect of a drug on pain does not seem necessarily to be related to its effect on mood. Further studies are needed to clarify this topic, and it will be necessary to examine specific pain conditions, compare different antidepressants, with reference to each other and to placebo, further investigate the role of drug plasma concentrations and control for the presence of concomitant psychiatric disturbances and for organic lesions responsible for the pain symptomatology.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723371     DOI: 10.2165/00003495-199142050-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  57 in total

1.  Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects.

Authors:  H Moldofsky; P Scarisbrick; R England; H Smythe
Journal:  Psychosom Med       Date:  1975 Jul-Aug       Impact factor: 4.312

2.  Maprotiline in chronic tension headache: a double-blind cross-over study.

Authors:  R Fogelholm; K Murros
Journal:  Headache       Date:  1985-07       Impact factor: 5.887

3.  Treatment of painful diabetic neuropathy with trazodone.

Authors:  R C Khurana
Journal:  JAMA       Date:  1983-09-16       Impact factor: 56.272

Review 4.  The future for antidepressants: treatment of pain.

Authors:  R D France
Journal:  Psychopathology       Date:  1987       Impact factor: 1.944

5.  Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study.

Authors:  D Loldrup; M Langemark; H J Hansen; J Olesen; P Bech
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

Authors:  S Carette; G A McCain; D A Bell; A G Fam
Journal:  Arthritis Rheum       Date:  1986-05

Review 7.  Pain relief by antidepressants: possible modes of action.

Authors:  Charlotte Feinmann
Journal:  Pain       Date:  1985-09       Impact factor: 6.961

8.  Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: a randomized, double-blind, placebo-controlled study.

Authors:  G Davidoff; M Guarracini; E Roth; J Sliwa; G Yarkony
Journal:  Pain       Date:  1987-05       Impact factor: 6.961

9.  Tofranil in the treatment of low back pain.

Authors:  D G Jenkins; A F Ebbutt; C D Evans
Journal:  J Int Med Res       Date:  1976       Impact factor: 1.671

10.  A controlled study of amitriptyline in the treatment of chronic pain.

Authors:  I Pilowsky; E C Hallett; D L Bassett; P G Thomas; R K Penhall
Journal:  Pain       Date:  1982-10       Impact factor: 6.961

View more
  26 in total

Review 1.  Fundamentals of neurogastroenterology.

Authors:  J D Wood; D H Alpers; P L Andrews
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Antidepressants as analgesics: a review of randomized controlled trials.

Authors:  M E Lynch
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

Review 3.  Centrally acting agents and visceral sensitivity.

Authors:  J Fioramonti; L Bueno
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 4.  Treatment of bladder pain syndrome and interstitial cystitis: a systematic review.

Authors:  Carolina Pazin; Andréia Moreira de Souza Mitidieri; Ana Paula Moreira Silva; Maria Beatriz Ferreira Gurian; Omero Benedicto Poli-Neto; Julio Cesar Rosa-E-Silva
Journal:  Int Urogynecol J       Date:  2015-08-14       Impact factor: 2.894

5.  Interaction of opioids with antidepressant-induced antinociception.

Authors:  F Sierralta; G Pinardi; M Mendez; H F Miranda
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

6.  HS014, a selective melanocortin-4 (MC4) receptor antagonist, modulates the behavioral effects of morphine in mice.

Authors:  N Eser Ercil; Ruggero Galici; Robert A Kesterson
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

7.  Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial.

Authors:  Ernest P Bouras; Nicholas J Talley; Michael Camilleri; Duane D Burton; Michael G Heckman; Julia E Crook; Elliott Richelson
Journal:  Am J Gastroenterol       Date:  2008-08       Impact factor: 10.864

8.  A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache.

Authors:  M Porta
Journal:  Curr Rev Pain       Date:  2000

9.  Opioid and Nonopioid Therapy in Cancer Pain: The Traditional and the New.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 10.  Management of insomnia in patients with chronic pain conditions.

Authors:  Frederic Stiefel; Daniele Stagno
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.